Who owns PHIO PHARMACEUTICALS CORP?

Tip: Access positions for across all investors

Analyze quarterly positions in Phio Pharmaceuticals Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Phio Pharmaceuticals Corp stock

Who bought or sold PHIO PHARMACEUTICALS CORP this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 93k $97k 60% Dec 2025
 View chart
Vanguard Group 88k $92k 0% Dec 2025
 View chart
Cetera Investment Advisers 43k $45k 27% Dec 2025
 View chart
Northern Trust 24k $25k 100% Dec 2025
 View chart
DRW Holdings 23k $24k 100% Dec 2025
 View chart
Susquehanna International 20k $21k 100% Dec 2025
 View chart
Intl Fcstone 12k $12k 100% Dec 2025
 View chart
Robertson Stephens Wealth Management 11k $11k 100% Dec 2025
 View chart
Virtu Financial 10k $11k 100% Dec 2025
 View chart
Captrust Financial Advisors 10k $11k 100% Dec 2025
 View chart
UBS Group 8.6k $9.1k 66008% Dec 2025
 View chart
SBI Securities 1.1k $1.2k 3% Dec 2025
 View chart
Assetmark 110.00 $115.995000 0% Dec 2025
 View chart
Activest Wealth Management 9.00 $9.000000 0% Dec 2025
 View chart

Who sold out of Phio Pharmaceuticals Corp?

Fund or Company Name Date Sold Shares Held Valued At
Royal Bank of Canada Jun 2025 3.5k $8.0k
Bnp Paribas Arbitrage, Snc Sep 2025 413.00 $1.0k
Tower Research Capital Sep 2025 406.00 $1.0k